- Kara Hoadley
- Kirk Schubert
Pharmacist education is necessary as new guidelines and literature are released. This educational series help pharmacists to practice consistently with the most current and evidence based practices. Pharmacy Residents will present Grand Rounds each year on a variety of topics. The drug information presented will be available for pharmacist education and CE.
Pharmacists and Pharmacy Technicians
Kara Hoadley, PharmD, Chair
Kirk Schubert, PharmD
Steve Kerchner, Pharmacy Tech
Ellyn Polley, Pharm D
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
A maximum of 1.5 hour of knowledge-based CE credit can be earned by successfully completing this live activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance, will be provided to NABP within 60 days after the activity completion.
2019 Universal Activity Number (UAN) JA0000358-0000-19-044-L04-P
2020 Universal Activity Number (UAN) JA0000358-0000-20-010-L04-P
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.15 continuing education units (CEUs) or 1.5 hours.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
As a result of participation in this educational series, participants will be able to:
- Improve therapeutic knowledge.
- Recommend appropriate use of medications based on evidence based medicine.
- Identify examples of practice changes that resulted from the guidelines.